S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

Elevance Health (ELV) Earnings Date, Estimates & Call Transcripts

$499.11
-2.14 (-0.43%)
(As of 03/1/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 17Estimated
Actual EPS
(Jan. 24)
$5.62 Beat By $0.02
Consensus EPS
(Jan. 24)
$5.60
Skip Charts & View Estimated and Actual Earnings Data

ELV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevance Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$10.47$10.87$10.62 
Q2 20243$9.91$10.32$10.15 
Q3 20243$9.66$10.04$9.84 
Q4 20244$6.57$7.19$6.85 
FY 202413$36.61$38.42$37.46 
Q1 20252$11.50$11.77$11.64 
Q2 20252$11.43$11.66$11.55 
Q3 20252$10.74$11.16$10.95 
Q4 20252$7.34$7.61$7.48 
FY 20258$41.01$42.20 $41.61

ELV Earnings Date and Information

Elevance Health last released its earnings results on January 24th, 2024. The reported $5.62 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.02. The firm earned $42.45 billion during the quarter, compared to the consensus estimate of $42.19 billion. Its quarterly revenue was up 7.0% on a year-over-year basis. Elevance Health has generated $25.17 earnings per share over the last year ($25.17 diluted earnings per share) and currently has a price-to-earnings ratio of 19.8. Earnings for Elevance Health are expected to grow by 11.66% in the coming year, from $37.15 to $41.48 per share. Elevance Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 17th, 2024 based off prior year's report dates.

Elevance Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/17/2024
Estimated)
------- 
1/24/2024Q4 2023$5.60$5.62+$0.02$7.61$42.19 billion$42.45 billion    
10/18/2023Q3 2023$8.45$8.99+$0.54$12.53$42.69 billion$42.48 billion      
7/19/2023Q2 2023$8.78$9.04+$0.26$10.29$41.64 billion$43.38 billion      
4/19/2023Q1 2023$9.26$9.46+$0.20$10.62$40.93 billion$41.90 billion      
1/25/2023Q4 2022$5.20$5.23+$0.03$6.53$39.62 billion$39.67 billion    
10/19/2022Q3 2022$7.10$7.53+$0.43$8.38$39.07 billion$39.63 billion      
7/20/2022Q2 2022$7.72$8.04+$0.32$9.29$38.05 billion$38.48 billion      
4/20/2022Q1 2022$7.81$8.25+$0.44$9.11$37.28 billion$38.10 billion      
1/26/2022Q4 2021$5.11$5.14+$0.03$5.65$36.47 billion$36.00 billion    
10/19/2021Q3 2021$6.37$6.79+$0.42$7.45$35.35 billion$35.55 billion    
7/20/2021Q2 2021$6.34$7.03+$0.69$6.81$33.22 billion$33.28 billion      
4/20/2021Q1 2021$6.86$7.01+$0.15$7.31$32.98 billion$32.10 billion    












Elevance Health Earnings - Frequently Asked Questions

When is Elevance Health's earnings date?

Elevance Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 17th, 2024 based off last year's report dates. Learn more on ELV's earnings history.

Did Elevance Health beat their earnings estimates last quarter?

In the previous quarter, Elevance Health (NYSE:ELV) reported $5.62 earnings per share (EPS) to beat the analysts' consensus estimate of $5.60 by $0.02. Learn more on analysts' earnings estimate vs. ELV's actual earnings.

How can I listen to Elevance Health's earnings conference call?

The conference call for Elevance Health's latest earnings report can be listened to online. Listen to Conference Call

How can I read Elevance Health's conference call transcript?

The conference call transcript for Elevance Health's latest earnings report can be read online. Read Transcript

How much revenue does Elevance Health generate each year?

Elevance Health (NYSE:ELV) has a recorded annual revenue of $171.34 billion.

How much profit does Elevance Health generate each year?

Elevance Health (NYSE:ELV) has a recorded net income of $5.99 billion. ELV has generated $25.17 earnings per share over the last four quarters.

What is Elevance Health's price-to-earnings ratio?

Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 19.83 and a forward price-to-earnings ratio of 13.43. The price/earnings-to-growth ratio is 1.12.

What is Elevance Health's EPS forecast for next year?

Elevance Health's earnings are expected to grow from $37.15 per share to $41.48 per share in the next year, which is a 11.66% increase.


More Earnings Resources from MarketBeat

This page (NYSE:ELV) was last updated on 3/3/2024 by MarketBeat.com Staff